Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Citation
Big PhRMA Payoff: Hidden Tax on Pedialyte, Prenatal Vitamins, and Pain Relievers
Newsletter
Re-importing Drugs, TARP for Small Business and Palin on ClimateGate
The Senate health care debate stalls on the question of whether to permit the re-importation of drugs from countries with price controls. President Obama announces…
Study
Congressional Misdiagnosis
Why Repealing McCarran-Ferguson Will Harm Competition in Health Insurance Markets…
News Release
Stripping Insurers’ Antitrust Exemption is a Congressional Misdiagnosis, New Report Shows
Stripping Insurers’ Antitrust Exemption is a Congressional Misdiagnosis, New Report Shows McCarran-Ferguson Repeal Won’t Help Consumers, May Hurt Competition Washington, D.C., December 8,…
Newsletter
Sarbanes-Oxley in Court, Swine Flu Peaks and Trade Deficits in Perspective
The U.S. Supreme Court hears arguments challenging the legitimacy of the Sarbanes-Oxley corporate accounting law. Swine flu infections have peaked and are declining, according to…
Overlawyered